Login / Signup

Strongyloides stercoralis Hyperinfection in an HIV-Infected Patient Successfully Treated with Subcutaneous Ivermectin.

Paolo Antonio GrossiDomenico LombardiAlessia PetroloCristina RovelliZaira Di RosaGiorgio PerriccioliAgostino RossiGiulio MinojaFrancesco ScaglioneDaniela Dalla Gasperina
Published in: Tropical medicine and infectious disease (2018)
A 39-year-old Ethiopian HIV-positive man with peripheral T-cell lymphoma developed Strongyloides stercoralis hyperinfection. The patient was initially treated with oral ivermectin for three weeks without response, most likely due to malabsorption because of concomitant paralytic ileus. Given the persistence of larvae in the body fluids, the worsening respiratory status and clinical malabsorption, veterinary parenteral formulation of ivermectin was administered. The very high plasma concentration of ivermectin achieved in the patient after parenteral administration led to a rapid improvement in his clinical condition and rapid disappearance of the parasite from biological samples, without any adverse reaction.
Keyphrases